CHELSEA THERAPEUTICS INTERNATIONAL

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), and related conditions and diseases along with its development of prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammat... ory bowel disease and cancer. As of December 31, 2009, it was focused on its drug development resources on two clinical stage development projects: droxidopa for symptomatic NOH and other potential indications, and its portfolio of non-metabolized antifolate compounds for the treatment of rheumatoid arthritis.
CHELSEA THERAPEUTICS INTERNATIONAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Charlotte, North Carolina, United States
Country:
United States
Website Url:
http://www.chelseatherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(704) 341-1516
Total Funding:
39.02 M USD
Technology used in webpage:
IIS 6 Level 3 Communications Omniture SiteCatalyst Digg Defense Net
Current Advisors List
Advisor
Advisor
Board_member
Board_member
Advisor
Board_member
2004-09-01
Board_member
Advisor
Current Employees Featured
J.Nick Riehle Vice President, Administration and CFO @ Chelsea Therapeutics International
Vice President, Administration and CFO
L. Arthur Hewitt Chief Scientific Officer @ Chelsea Therapeutics International
Chief Scientific Officer
Michael J. Roberts Vice President, Business Development @ Chelsea Therapeutics International
Vice President, Business Development
Joseph G. Oliveto Interim Chief Executive Officer @ Chelsea Therapeutics International
Interim Chief Executive Officer
Founder
Stock Details
Investors List
Venrock
Venrock investment in Post-IPO Equity - Chelsea Therapeutics International
Paramount BioCapital Asset Management
Paramount BioCapital Asset Management investment in Post-IPO Equity - Chelsea Therapeutics International
Official Site Inspections
http://www.chelseatherapeutics.com
- Host name: 216.21.224.199
- IP address: 216.21.224.199
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
